Skip to content

Opening book details…

About this Immunology and Microbiology article

Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy by J. I. Jorquera is a Immunology and Microbiology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Immunology and Microbiology.

Author
J. I. Jorquera
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 0009-9104)
Published
2009
Field
Immunology and Microbiology (Life Sciences)

More by J. I. Jorquera

Browse all works by J. I. Jorquera